The Intramuscular HPV Vaccination Market is positioned for significant expansion as the global healthcare industry places greater emphasis on preventive medicine. The market was estimated at USD 1.99 billion in 2023 and is projected to reach USD 9.3 billion by 2032, representing a CAGR of 18.71%. Rising HPV prevalence is one of the key factors supporting market growth. Increased awareness...